In a landmark event set to redefine the multidisciplinary approach toward neurological and psychiatric health, UCLA Health is hosting its inaugural Brain Health Summit on March 20-21, 2026. This summit aims to unify the fragmented efforts of scientists, policymakers, philanthropists, and community advocates to confront the daunting and underfunded challenges plaguing the domain of brain health. By bridging traditionally siloed disciplines, the conference seeks to generate actionable strategies for elevating brain health as a national public health priority.
Disorders of the brain and nervous system represent a colossal public health burden, affecting over 180 million Americans, according to a groundbreaking 2025 study published in JAMA Neurology. This encompasses a broad spectrum of conditions, including neurological diseases, neurodevelopmental impairments, and mental health disorders. Neuroscience funding at the federal level, however, saw a significant decline in 2023, compelling researchers and advocates to seek alternative pathways. To compound this issue, the leadership vacuum at the national policy level threatens the momentum required for sustained scientific innovation and therapeutic advances.
Remarkably, momentum in brain research funding and policy initiatives is emerging at both state and international levels. Texas voters recently approved an unprecedented $3 billion allocation for brain disease research in 2025, signaling a shift in public willingness to invest in neuroscience. Concurrently, frameworks addressing the “brain economy” are gaining traction at the World Economic Forum in Davos, highlighting the economic and societal implications of brain health. These developments demonstrate an emergent global acknowledgment that brain disorders are not just medical issues but critical levers of economic productivity and societal well-being.
The UCLA Brain Health Summit uniquely combines expertise across multiple layers of brain science and care, fostering conversations among neurologists, pediatric clinicians, aging specialists, developmental neuroscience researchers, and even artists and patients. This cross-disciplinary dialogue is aimed at catalyzing comprehensive solutions to prioritize brain health across the lifespan. The conference transcends traditional academic boundaries, reflecting an understanding that brain health intricately intersects with environmental, social, and creative factors.
One of the summit’s key thematic focal points is the analysis of brain health policy and funding landscapes amid shrinking federal investment. Discussions will delve into state-led initiatives, philanthropic efforts, and private sector contributions as compensatory mechanisms. The conference will critically evaluate funding patterns and advocate for integrated models that sustain neuroscience research and clinical translation in an era of fiscal retrenchment.
Technological innovation, especially the integration of artificial intelligence (AI), is another domain slated for intensive exploration. AI’s potential to enhance cognitive health monitoring, predict disease trajectories, and personalize treatment regimens underscores the transformative impact of computational neuroscience. Speakers will assess the current capabilities and future prospects of AI-driven interventions, probing their ethical dimensions and scalability challenges within clinical neuroscience frameworks.
Lifestyle modifiable factors such as sleep hygiene, breathwork, nutrition, and physical exercise also feature prominently in the summit’s agenda. Emerging scientific literature increasingly implicates these elements as critical determinants of neuroplasticity, cognitive resilience, and neurodegenerative disease prevention. The symposium seeks to bridge basic neuroscience and public health by disseminating evidence-based guidance that could empower individuals to adopt brain-healthy behaviors.
Childhood brain health and neurodevelopmental disorders occupy a significant share of the discussions, focusing on early environmental exposures and their long-term neurocognitive consequences. This segment underlines the importance of early-life interventions to mitigate developmental disabilities and optimize lifelong brain function. The integration of pediatric neuropsychology with environmental neuroscience epitomizes the summit’s holistic approach.
Furthermore, the conference will highlight innovative neurological care models that incorporate arts, music, dance, and creativity as therapeutic tools. The neurobiological underpinnings of these modalities reveal their potential to modulate brain circuits involved in emotion regulation, motor function, and cognition. This novel incorporation of creative therapies challenges conventional biomedical paradigms and proposes enriched patient-centered approaches.
Patient and caregiver experiences will provide indispensable qualitative insights at the summit, emphasizing the lived realities of brain diseases. These perspectives are integral to shaping healthcare delivery systems that are compassionate, equitable, and responsive to the complex challenges faced by affected individuals and their families.
An ambitious scientific undertaking discussed at the summit is the conceptualization of a national Brain Health Index—a composite metric aimed at quantitatively assessing brain health across populations. Such an index would integrate neurobiological markers, cognitive performance parameters, and socio-environmental variables, facilitating epidemiological surveillance, personalized diagnostics, and policy evaluation.
A prestigious roster of speakers from diverse institutions tops the summit’s lineup. Notables include Steve Carnevale, Commissioner of the California Commission on Behavioral Health; Daniel Geschwind, UCLA’s Senior Dean and Vice Chancellor for Precision Medicine; Harris Eyre from the Global Brain Economy Initiative at Rice University; and Kana Enomoto of the McKinsey Health Institute, delivering a keynote on human cognitive advantage within the AI epoch. Cognitive neuroscientists, mental health pioneers, and innovative artists collectively enrich the discourse.
Held at the UCLA Meyer and Renee Luskin Conference Center in Los Angeles, the two-day summit is accessible via live stream without registration, encouraging broad participation. Attendance inquiries may be directed to UCLA Health media relations to facilitate engagement among researchers, practitioners, and advocates interested in advancing brain health science and policy.
In conclusion, UCLA’s first Brain Health Summit marks a pivotal moment for neuroscience, catalyzing integrated, multidisciplinary efforts to combat the escalating burden of brain disorders. By harnessing innovations in technology, policy, lifestyle science, and creative therapies, this forum aspires to propel brain health into the mainstream public health agenda and inspire new paradigms for a healthier future.
Subject of Research: Neuroscience, brain health, neurological and psychiatric disorders, brain health policy.
Article Title: UCLA Health Hosts First-Ever Brain Health Summit to Address National Neurological Challenges
News Publication Date: Not specified (Event date March 20-21, 2026)
Web References: Not provided
References: 2025 JAMA Neurology study on brain and nervous system disorders
Image Credits: Not provided
Keywords: Neurology, mental health, psychiatric disorders, cognitive disorders, neuroscience, brain health policy, AI in cognitive health, neurodevelopment, neuroplasticity, neurodegenerative diseases, brain health index, brain economy.
